TY  - GEN
AU  - Jurcic,J G
AU  - Caron,P C
AU  - Miller,W H
AU  - Yao,T J
AU  - Maslak,P
AU  - Finn,R D
AU  - Larson,S M
AU  - Warrell,R P
AU  - Scheinberg,D A
TI  - Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195
SN  - 0887-6924
PY  - 1995///0330
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, Differentiation, Myelomonocytic
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Cell Differentiation
KW  - drug effects
KW  - Combined Modality Therapy
KW  - Cytarabine
KW  - administration & dosage
KW  - Daunorubicin
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Idarubicin
KW  - Immunologic Factors
KW  - Leukemia, Promyelocytic, Acute
KW  - mortality
KW  - Life Tables
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Proteins
KW  - Neoplasm, Residual
KW  - Neutropenia
KW  - etiology
KW  - Nuclear Proteins
KW  - Oncogene Proteins, Fusion
KW  - Polymerase Chain Reaction
KW  - Promyelocytic Leukemia Protein
KW  - Receptors, Retinoic Acid
KW  - Remission Induction
KW  - Salvage Therapy
KW  - Sialic Acid Binding Ig-like Lectin 3
KW  - Survival Analysis
KW  - Transcription Factors
KW  - Treatment Outcome
KW  - Tretinoin
KW  - pharmacology
KW  - Tumor Suppressor Proteins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -